Criterion Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Criterion Capital Advisors's LLY Position: Q4 2024 in Review
Criterion Capital Advisors held its Eli Lilly (LLY) position steady in Q4 2024 at 2,201 shares worth $1.99M. The position accounts for 1.25% of the portfolio, ranked #21.
Criterion Capital Advisors first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Criterion Capital Advisors held 2,201 shares of Eli Lilly worth $1.99M as of Q4 2024.
- Criterion Capital Advisors left its Eli Lilly share count unchanged in Q4 2024.
- Eli Lilly made up 1.25% of Criterion Capital Advisors's portfolio in Q4 2024, its #21 holding.
- Criterion Capital Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.